A substance that is being studied in the treatment of cancer. It may help tumor cells respond again to drugs they have become resistant (unable to respond) to. XR9576 is a type of multidrug resistance inhibitor and a type of P-glycoprotein antagonist. Also called tariquidar.
Source: NCI Dictionary of Cancer Terms
Search the Glossary of Medical Terms
Newsletter
Sign up for the QuackTrack.org newsletter below!